Dupixent (Dupilumab) for Eczema | MyEczemaTeam

Connect with others who understand.

sign up Log in
About MyEczemaTeam
Powered By

Dupixent is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat people 12 and up with moderate to severe atopic dermatitis in cases where traditional therapies are not safe or effective. Dupixent may be referred to by its drug name, dupilumab.

Dupixent is considered a biologic drug, and more specifically, an interleukin-4 (IL-4) receptor alpha antagonist. Dupixent is a genetically engineered molecule believed to work by blocking IL-4 and IL-13, chemical messengers involved in autoimmune attacks. Dupixent prevents IL-4 and IL-13 from signaling the immune system to attack the tissues.

How do I take it?
Dupixent is administered as a subcutaneous injection every other week after initial loading doses.

Dupixent is available as a prefilled single-use syringe.

Side effects
The FDA-approved label for Dupixent lists common side effects including injection site reactions, eye problems, throat pain, high white blood cell count, trouble sleeping, toothache, stomach flu, joint pain, and facial rash.

Rare but serious side effects listed for Dupixent can include severe eye problems, hypersensitivity reactions, and worsening asthma.

For more details about this treatment, visit:

Dupixent — Sanofi

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in